STOCK TITAN

Synergy Chc Corp Financials

SNYR
FY2025 annual
Revenue $30.4M +1.3% YoY
Net Income -$12.3M -680.8% YoY
EPS (Diluted) -$1.27 -553.6% YoY
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Synergy Chc Corp (SNYR) reported $30.4M in revenue for fiscal year 2025, up 1.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNYR FY2025

Stable sales conceal a sharp earnings reversal, while negative equity and financing flows increasingly shape the business’s operating mechanics.

Revenue fell from $42.8M in FY2023 to $30.4M in FY2025. That top-line decline was accompanied by a margin swing from 25.3% to -27.8%, indicating that cost absorption or mix—not volume alone—drives reported profitability.

FY2024 paired net income of $2.1M with operating cash flow of -$4.8M, so accounting profit did not translate into cash that year, suggesting balance-sheet movements mattered more than the income statement indicated. In FY2025, operating cash flow improved to -$2.6M even as net income fell to -$12.3M, reinforcing that working-capital or non-cash movements materially affect earnings quality.

FY2025 ended with negative equity of -$23.1M and long-term debt of $25.1M, making external financing a central balance-sheet feature rather than a peripheral one. Although the current ratio reached 1.2x, that short-term measure does not offset the broader mismatch between obligations and assets.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 9 / 100
Financial Health Score 9/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Synergy Chc Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
17

Synergy Chc Corp has an operating margin of -27.8%, meaning the company loses $28 on every $100 of revenue. This results in a profitability score of 17/100. This is down from 19.3% the prior year.

Growth
7

Synergy Chc Corp's revenue grew a modest 1.3% year-over-year to $30.4M. This slow but positive growth earns a score of 7/100.

Leverage
0

Not available for Synergy Chc Corp, and counted as zero in the overall score.

Liquidity
29

Synergy Chc Corp's current ratio of 1.22 is below the typical benchmark, resulting in a score of 29/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
0

Not available for Synergy Chc Corp, and counted as zero in the overall score.

Returns
1
Altman Z-Score Distress
-7.29

Synergy Chc Corp scores -7.29, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($1.6M) relative to total liabilities ($33.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

Synergy Chc Corp passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Synergy Chc Corp reported a net loss of $12.3M while operations used $2.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Synergy Chc Corp reported an operating loss of $8.5M against $2.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$30.4M
YoY+1.3%
5Y CAGR-3.1%

Synergy Chc Corp generated $30.4M in revenue in fiscal year 2025. This represents an increase of 1.3% from the prior year.

EBITDA
-$8.3M
YoY-240.3%

Synergy Chc Corp's EBITDA was -$8.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 240.3% from the prior year.

Net Income
-$12.3M
YoY-680.8%

Synergy Chc Corp reported -$12.3M in net income in fiscal year 2025. This represents a decrease of 680.8% from the prior year.

EPS (Diluted)
-$1.27
YoY-553.6%

Synergy Chc Corp earned -$1.27 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 553.6% from the prior year.

Cash & Balance Sheet

Cash & Debt
$2.6M
YoY+281.2%
5Y CAGR+6.0%

Synergy Chc Corp held $2.6M in cash against $25.1M in long-term debt as of fiscal year 2025.

Shares Outstanding
11M
YoY+29.2%

Synergy Chc Corp had 11M shares outstanding in fiscal year 2025. This represents an increase of 29.2% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
66.8%
YoY-12.0pp
5Y CAGR-5.6pp

Synergy Chc Corp's gross margin was 66.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 12.0 percentage points from the prior year.

Operating Margin
-27.8%
YoY-47.2pp
5Y CAGR-33.0pp

Synergy Chc Corp's operating margin was -27.8% in fiscal year 2025, reflecting core business profitability. This is down 47.2 percentage points from the prior year.

Net Margin
-40.6%
YoY-47.7pp
5Y CAGR-42.0pp

Synergy Chc Corp's net profit margin was -40.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 47.7 percentage points from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

SNYR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNYR quarterly income statement
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Revenue$5.5MN/A$8.0M-1.5%$8.1M-72.9%$30.0M+451.8%$5.4M-23.7%$7.1M-11.2%$8.0M
Cost of Revenue$1.5MN/A$2.3M+22.8%$1.9M-5.5%$2.0M-46.8%$3.8M+61.4%$2.3M-4.6%$2.4M
Gross Profit$4.0MN/A$5.7M-8.9%$6.2M+1.2%$6.2M-5.2%$6.5M+35.7%$4.8M-14.1%$5.6M
SG&A Expenses$2.0MN/A$1.6M+7.8%$1.5M+16.3%$1.3M+3.1%$1.3M+6.0%$1.2M+32.4%$904K
Operating Income-$567KN/A$1.3M-21.2%$1.6M-16.6%$1.9M+43.4%$1.4M+29.3%$1.1M-33.6%$1.6M
Interest Expense$2.0MN/A$1.2M-44.8%$2.1M+469.7%$370K+4659.4%$8K-97.9%$378K-49.3%$746K
Income Tax-$14KN/A-$11K-105.8%$190K+1758.9%-$11K+6.0%-$12K+93.7%-$192K-207.2%$179K
Net Income-$2.6MN/A$125K-91.5%$1.5M+68.1%$876K+729.3%$106K-86.5%$784K+19.6%$655K
EPS (Diluted)-$0.23+85.1%-$1.54-15500.0%$0.01-94.1%$0.17+70.0%$0.10+900.0%$0.01-90.9%$0.11+22.2%$0.09

Not reported in any period shown, so not listed: R&D Expenses.

SNYR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNYR quarterly balance sheet
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Total Assets$6.5M-36.4%$10.2M-50.9%$20.7M+4.9%$19.7M+26.0%$15.7M-4.2%$16.3M+34.3%$12.2MN/A
Current Assets$6.3M-36.6%$10.0M-51.2%$20.5M+5.1%$19.5M+26.6%$15.4M-4.1%$16.1M+35.5%$11.9MN/A
Cash & Equivalents$292K-88.9%$2.6M+160.5%$1.0M-31.0%$1.5M+720.0%$178K-74.1%$688K+165.2%$259K+38.5%$187K
Inventory$3.4M-9.5%$3.7M+74.2%$2.1M-9.2%$2.4M+0.8%$2.3M+36.7%$1.7M-10.2%$1.9MN/A
Accounts Receivable$1.3M-60.4%$3.2M-53.0%$6.8M-3.6%$7.1M+61.4%$4.4M-17.7%$5.3M+30.7%$4.1MN/A
Total Liabilities$31.9M-4.3%$33.3M+15.0%$28.9M-9.8%$32.1M+2.6%$31.3M-5.1%$33.0M-11.7%$37.3MN/A
Current Liabilities$6.8M-16.8%$8.2M+115.0%$3.8M-46.3%$7.1M-11.6%$8.1M-53.1%$17.2M-5.8%$18.2MN/A
Long-Term Debt$25.0M-0.2%$25.1M-0.2%$25.1M+0.5%$25.0M+129.2%$10.9M+46.1%$7.5MN/AN/A
Total Equity-$25.4M-9.8%-$23.1M-180.3%-$8.3M+33.3%-$12.4M+20.8%-$15.6M+6.0%-$16.6M+33.9%-$25.2M+2.7%-$25.9M
Retained Earnings-$59.0M-4.6%-$56.4M-35.6%-$41.6M+0.3%-$41.8M+3.4%-$43.2M+2.0%-$44.1M+0.5%-$44.3MN/A

Not reported in any period shown, so not listed: Goodwill.

SNYR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNYR quarterly cash flow statement
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Operating Cash Flow-$2.0M-427.6%$624K+127.0%-$2.3M-2901.2%-$77K+90.6%-$823K+76.0%-$3.4M-1342.6%-$237K+15.8%-$282K
Financing Cash Flow-$308K-127.0%$1.1M-39.5%$1.9M+42.9%$1.3M+318.8%$315K-91.9%$3.9M+699.9%$489K+181.8%-$597K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.

SNYR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SNYR quarterly financial ratios
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Gross Margin72.3%N/A70.9%-5.8pp76.7%+56.1pp20.5%119.6%67.2%-2.3pp69.5%
Operating Margin-10.3%N/A16.0%-4.0pp20.0%+13.5pp6.5%-18.5pp25.0%+10.2pp14.8%-5.0pp19.7%
Net Margin-46.8%N/A1.6%-16.6pp18.1%+15.2pp2.9%+1.0pp1.9%-9.1pp11.0%+2.8pp8.2%
Return on Assets-39.8%N/A0.6%-6.9pp7.5%+1.9pp5.6%+5.0pp0.7%-5.8pp6.4%N/A
Current Ratio0.93-0.3x1.22-4.1x5.35+2.6x2.74+0.8x1.91+1.0x0.93+0.3x0.65N/A

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin.

Note: Shareholder equity is negative (-$23.1M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

What is Synergy Chc Corp's annual revenue?

Synergy Chc Corp (SNYR) reported $30.4M in total revenue for fiscal year 2025. This represents a 1.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Synergy Chc Corp's revenue growing?

Synergy Chc Corp (SNYR) revenue grew by 1.3% year-over-year, from $30.0M to $30.4M in fiscal year 2025.

Is Synergy Chc Corp profitable?

No, Synergy Chc Corp (SNYR) reported a net income of -$12.3M in fiscal year 2025, with a net profit margin of -40.6%.

Synergy Chc Corp (SNYR) reported diluted earnings per share of -$1.27 for fiscal year 2025. This represents a -553.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Synergy Chc Corp (SNYR) had EBITDA of -$8.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Synergy Chc Corp (SNYR) had $2.6M in cash and equivalents against $25.1M in long-term debt.

Synergy Chc Corp (SNYR) had a gross margin of 66.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Synergy Chc Corp (SNYR) had an operating margin of -27.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Synergy Chc Corp (SNYR) had a net profit margin of -40.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Synergy Chc Corp (SNYR) recorded an outflow of $2.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Synergy Chc Corp (SNYR) had $10.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Synergy Chc Corp (SNYR) had 11M shares outstanding as of fiscal year 2025.

Synergy Chc Corp (SNYR) had a current ratio of 1.22 as of fiscal year 2025, which is considered adequate.

Synergy Chc Corp (SNYR) had a return on assets of -121.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Synergy Chc Corp (SNYR) held $2.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.6M over that year. Dividing the one by the other, the reported balance equals about 12 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Synergy Chc Corp (SNYR) has negative shareholder equity of -$23.1M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Synergy Chc Corp (SNYR) has an Altman Z-Score of -7.29, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Synergy Chc Corp (SNYR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Synergy Chc Corp (SNYR) reported a net loss of $12.3M while operations used $2.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Synergy Chc Corp (SNYR) reported an operating loss of $8.5M against $2.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Synergy Chc Corp (SNYR) scores 9 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top